The contract follows a competitive national procurement process and establishes TetraGraph as the only quantitative neuromuscular monitoring solution currently available through the VA Strategic Acquisition Center’s national contracting program.

The contract provides more than 170 VA hospitals and healthcare facilities across the nation’s largest integrated healthcare system with streamlined access to Senzime’s TetraGraph quantitative neuromuscular monitoring technology through pre-negotiated pricing and a simplified procurement process. Through the VA Strategic Acquisition Center’s national contracting program, eligible facilities can rapidly implement evidence-based quantitative neuromuscular monitoring without the need for separate local competitive procurements.

“This national contract award represents another significant milestone for Senzime and reflects the increasing recognition of quantitative neuromuscular monitoring as an essential component of modern anesthesia practice,” says Philip Siberg, Chief Executive Officer of Senzime. “Through our partnership with TrillaMed, VA hospitals nationwide will have streamlined access to TetraGraph technology, enabling clinicians to provide Veterans with the highest standard of perioperative care. We believe this agreement will substantially expand the adoption of our technology throughout the VA healthcare system over the next five years.”